Breast Cancer

The Pharmacy Times® Breast Cancer resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
Lenvatinib (Lenvima) plus pembrolizumab (Keytruda) showed early antitumor activity and tolerability in previously treated triple-negative breast cancer patients with advanced solid tumors.
[[thumbnail_alt_text]]
Trial shows that olaparib, a poly ADP ribose polymerase inhibitor that is the first cancer drug to target an inherited genetic fault, can be used successfully to treat prostate cancers with a weakness in the ability to repair damaged DNA.
[[thumbnail_alt_text]]
Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer.
[[thumbnail_alt_text]]
Study shows the recurrence rate was within the expected range for breast cancer survivors receiving spironolactone and those who did not.
 
[[thumbnail_alt_text]]
A new test may help direct treatments for patients with rare breast cancer mutations. 
[[thumbnail_alt_text]]
Understanding the role of abemaciclib (Verzenio) in managing patients with hormone receptor positive and human epidermal growth factor receptor 2 negative metastatic breast cancer is crucial.
[[thumbnail_alt_text]]
It may take cells in different stages of development to cause breast cancer to progress and spread, according to recent research published in eLife.
[[thumbnail_alt_text]]
Figuring out how to target vulnerable cells in breast cancer tumors can help treat the disease more effectively. 
 
[[thumbnail_alt_text]]
Jacob Kettle, PharmD, BCOP, and Allison Butts, PharmD, BCOP, share some future therapies for the management of breast cancer.
[[thumbnail_alt_text]]
The current study found no link between personal use of permanent hair dye and the risk of most cancers or cancer-related mortality.
[[thumbnail_alt_text]]
Jacob Kettle, PharmD, BCOP, and Allison Butts, PharmD, BCOP, consider the influence of COVID-19 on the therapeutic choice for patients.
[[thumbnail_alt_text]]
Oral chemotherapy may be an important option for patients during the COVID-19 pandemic, as it would allow them to receive treatment at home.